Industries
CQV experience aligned with complex regulated manufacturing
Augmented supports organizations where facility, equipment, automation, process, and quality-system decisions must converge into controlled manufacturing operation.
Manufacturing environments
Technical context across modalities and project models
Qualification strategy is shaped by the intended manufacturing use, risk profile, operating model, and maturity of the supporting evidence.
Biopharmaceutical Manufacturing
- Upstream processing
- Downstream processing
- Clean utilities
- Process support systems
- Facility and equipment qualification
Cell and Gene Therapy
- Controlled manufacturing environments
- Cell-processing equipment
- Cold-chain and material-flow considerations
- Cleanroom and support-system readiness
- Clinical-to-commercial scale transitions
Clinical Manufacturing
- New cGMP facility readiness
- Flexible and multiproduct operations
- Rapid project timelines
- Risk-based qualification
- Manufacturing startup support
Pharmaceutical Manufacturing
- Facilities
- Utilities
- Process equipment
- Packaging and support systems
- Computerized and automated systems
Advanced Therapies
- Viral-vector operations
- Personalized manufacturing
- Specialized equipment and environments
- Modality-specific risk considerations
- Complex material and data flows
Engineering and Project-Delivery Partners
- CQV strategy alignment
- Owner-requirement interpretation
- Vendor-document assessment
- Qualification work packages
- Turnover and closeout support
Discuss your facility, system, or project
Start with the manufacturing context, project phase, and qualification challenge that need attention.